VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1652782
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: arm was sore; This is a spontaneous report based on the information received by Pfizer from Novartis Pharmaceuticals Corporation (Reference ID: NVSC2020US319232_OS). A contactable consumer (patient) reported that an 83-years-old female patient received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced arm was sore. The outcome of event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652783
Sex: F
Age:
State: NY

Vax Date: 06/16/2021
Onset Date: 06/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Woke up with dizzy; Wake up with fever; Numbness across body especially legs and toes.; This is a spontaneous report from a contactable consumer. A 12-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via an unspecified route of administration in the arm left on 16Jun2021 at 10:15 as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medications. The patient had no known allergies. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via an unspecified route of administration in the left arm on 25May2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Jun2021 at 06:00, the patient reported that she woke up dizzy, with fever and numbness across body, especially legs and toes. 6 hours after waking dizziness was less intense but toes and calves are still somewhat numb but feeling was improved. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event woke up with dizziness, numbness and fever was recovering at the time of this report. The batch/lot numbers for BNT162b2 were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652784
Sex: F
Age:
State: MO

Vax Date: 06/16/2021
Onset Date: 06/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210617; Test Name: Body temperature; Result Unstructured Data: Test Result:100.5 Units:[degF]; Comments: Fever 100.5 F

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Very fatigued; Low grade fever 100.5F; Chills; Upset stomach; This is a spontaneous report from a contactable consumer. A 13-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG6207), via intramuscular route of administration in the left arm on 16Jun2021 at 09:30 (at the age of 13-years-old), as a single dose for COVID-19 immunisation. Medical history included ADHD. The patient did not have any allergies to medications, food or other products. Concomitant medications included methylphenidate hydrochloride (RITALIN) and levocetirizine dihydrochloride (XYZAL); both from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG6207), via intramuscular route of administration in the left arm on an unknown date in May2021 at 15:00 (at the age of 13-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Jun2021 at 01:30, the patient experienced very fatigued, low-grade fever 100.5F, chills and upset stomach. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 17Jun2021 at 01:30, the patient underwent lab test and procedure which included body temperature and the result was shown as 100.5 F. The clinical outcome of the events very fatigued, low-grade fever 100.5F, chills and upset stomach were resolving at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds: RITALIN; XYZAL

Current Illness:

ID: 1652785
Sex: M
Age:
State: WA

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Within 2 hours of receiving the 2nd dose of the covid vaccine I began to have intense stomach pain in my intestines / At times it feels like needles inside my intestines stabbing me internally.; I have had indigestion and pain in my abdomen and stomach for 1 month straight.; I have had indigestion and pain in my abdomen and stomach for 1 month straight.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 15May2021 at 12:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included buprenorphine hydrochloride 8.6mg, naloxone hydrochloride 2.1mg (ZUBSOLV) and ibuprofen 400mg (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 17Apr2021 at 12:00 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 14:00, Within 2 hours of receiving the 2nd dose of the COVID vaccine the patient began to have intense stomach pain in the intestines. The patient had indigestion and pain in abdomen and stomach for 1 month straight. "The pain comes and goes. At times it feels like needles inside my intestines stabbing me internally. I am in horrible pain every day". The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events intense stomach pain in the intestines, indigestion and pain in abdomen and stomach for 1 month straight was not recovered at the time of this report. The lot number for BNT162b2, were not provided and will be requested during follow up.

Other Meds: ZUBSOLV; IBUPROFEN

Current Illness:

ID: 1652786
Sex: F
Age:
State: CA

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Fatigue for two months with some dizziness.; Fatigue for two months with some dizziness.; balance with yoga and pilates is off; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 03Apr2021 at 11:15 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included Sjogren's syndrome, migraine and sulfonamide allergy. Concomitant medications included ubidecarenone (COQ10), vitamin d nos (VIT D), ascorbic acid (VIT C), curcuma longa rhizome (TURMERIC) and biotin (MANUFACTURER UNKNOWN) all from an unknown date and unknown if ongoing for an unknown indication. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 13Mar2021 at 11:15 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, the patient experienced fatigue for two months with some dizziness, unusual for her, usually had lots of energy and her balance was great, forced herself to do her usual routine, but felt fatigued and balance with yoga and pilates was off. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events fatigue for two months with some dizziness and balance with yoga and pilates was off was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: COQ10 [UBIDECARENONE]; VIT D [VITAMIN D NOS]; VIT C; TURMERIC [CURCUMA LONGA RHIZOME]; BIOTIN

Current Illness:

ID: 1652787
Sex: F
Age:
State:

Vax Date: 06/14/2021
Onset Date: 06/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Rash with itching; Pain at injection site.; Pain and inflammation increasing on day 3.; Dose 1: 28May2021; Dose 2: 14Jun2021; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Jun2021 at 10:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28May2021 at 11:00, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Jun2021 at 10:00, 24 hours after vaccination, the patient experienced rash with itching and pain at injection site. The patient stated that the pain and inflammation was increasing on day 3. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash with itching and pain at injection site and inflammation was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652788
Sex: F
Age:
State: TX

Vax Date: 05/23/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Body aches, pains, tiredness; Body aches, pains, tiredness; This is a spontaneous report from a contactable consumer or other non-health care professional re-ported for female patient (reporter's niece). A 23-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot num-ber was not reported), via an unspecified route of administration (at the age of 23-years), adminis-tered in arm on 23May2021 as dose 2, single for COVID-19 immunization. Medical history included none and family history of diabetes mellitus the patient dad was diabetic, but caller does not know for sure from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration (at the age of 23-years), on an unspecified date as dose 1, single for COVID-19 immunization and stated that it was maybe 3 weeks before the second dose and experienced no reac-tion on previous exposure to drug. On an unspecified date, the patient experienced body aches, pains, tiredness. Reporter also mentioned that his niece developed minor adverse events after the second dose of the vaccine. Caller was not sure when this started for the patient but caller states that it did not go away completely right away but the patient told the caller that she is getting better, not getting worse. The adverse event does not result in emergency room and physician office. Reporter was calling for his niece had the second dose of the Pfizer COVID-19 vaccine 10 days ago. The day before yesterday, his niece had an appointment for the hepatitis B vaccine. By mistake, the pharmacist had administered the Pfizer COVID19 vaccine to his niece and now his niece is experiencing adverse events that are similar to the adverse events she has experienced during her Pfizer COVID-19 vaccine second dose. Reporter wanted to know how safe having a third dose of the Pfizer COVID-19 vaccine was and he wanted to know what to do at this point. The patient was taking Pfizer Covid 19 vaccine as preventative. The clinical outcome for the events was reported as recovering. Information regarding the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1652789
Sex: M
Age:
State: TX

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Numbness in left hand; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 01May2021 at 14:30(at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had no known allergies. The patient received other medications in two to three weeks, names unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 18:00, the patient experienced numbness in left hand. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event numbness in left hand was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652790
Sex: F
Age:
State: NJ

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: shoulder pain; decrease range of motion on shoulder; This is a spontaneous report from a contactable nurse, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK9231) via an unspecified route of administration in the right arm on 13Jan2021 at 10:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included graves' disease. The patient previously took nitrofurantoin (MACROBID) for an unknown indication on an unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via an unspecified route of administration in the left arm on 23Dec2020 at 20:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any medicines within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Jan2021, the patient experienced shoulder pain and decrease range of motion on shoulder which was persisting 6 months after getting COVID-19 vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events of shoulder pain and decrease range of motion on shoulder was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652791
Sex: U
Age:
State: OH

Vax Date: 06/11/2021
Onset Date: 06/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Knot above collarbone; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Jun2021 at 12:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Patient had no relevant medical history. The patient previously took tetanus shot vaccine on an unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN EXTRA STRENGTH) and paracetamol (TYLENOL); both for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Jun2021, the patient experienced knot above collarbone. It was unknown whether the patient received any treatment for the adverse event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event knot above collarbone was unknown at the time of this report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds: EXCEDRIN EXTRA STRENGTH; TYLENOL

Current Illness:

ID: 1652792
Sex: F
Age:
State: OH

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: There was sharp pain through the breast; breast is still tender two months later.; Enlarged lymph nodes under the arm and in breast on the side the shot was given; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 10:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies to medications, food or other products. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 10:00. the patient experienced enlarged lymph nodes under the arm and in breast on the side the shot was given. There was sharp pain through the breast and breast was still tender two months later. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event sharp pain through the breast, breast was still tender and enlarged lymph nodes under the arm and in breast was not recovered at the time of this report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652793
Sex: F
Age:
State: CT

Vax Date: 06/16/2021
Onset Date: 06/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Headache; Body aches; chills; This is a spontaneous report from a contactable consumer. A 15-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via intramuscular route of administration in the left arm on 16Jun2021 at 09:15 (at the age of 15-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Patient had nut allergy to hazelnuts, pistachios and cashews. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via intramuscular route of administration in the left arm on 26May2021 (at the age of 15-years-old) as a single dose for COVID-19 immunisation. Patient did not had any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Jun2021 at 22:00, the patient experienced body aches, chills and headache. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination the patient not been tested for COVID-19. The clinical outcome of the events of body aches, chills and headache was recovered on an unknown date in Jun2021.

Other Meds:

Current Illness:

ID: 1652794
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 06/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Pain site; Tiredness; Headache; Muscle pain; Feeling unwell; Arm pain; Nausea; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on an unknown date in 2021, as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. The patient had no known allergies. Concomitant medications included anxiety medications (MANUFACTURER UNKNOWN), on an unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on an unknown date in 2021 at 14:00, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Jun2021 at 00:00, the patient experienced pain site, tiredness, headache, muscle pain, feeling unwell, arm pain, nausea, fever and chills. . Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain site, tiredness, headache, muscle pain, feeling unwell, arm pain, nausea, fever and chills was not recovered at the time of this report. The batch/lot numbers for BNT162b2 were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652795
Sex: F
Age:
State: AZ

Vax Date: 06/16/2021
Onset Date: 06/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Fatigue; Feeling unwell; Nausea; Vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 14-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0180) via an unspecified route of administration in the left arm on 16Jun2021 at 12:15 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included sertraline hydrochloride (ZOLOFT) and doxycycline (MANUFACTURER UNKNOWN); for unknown indication from unknown date and unknown if ongoing. The patient previously received azithromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Jun2021 at 16:00, the patient experienced fatigue, feeling unwell, nausea and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fatigue, feeling unwell, nausea and vomiting were not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ZOLOFT; DOXYCYCLINE

Current Illness:

ID: 1652796
Sex: M
Age:
State: NJ

Vax Date: 06/14/2021
Onset Date: 06/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Rash; Light pain in arm; Headache; light-headedness; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Jun2021 at 10:15 (at the age of 13-year-old) as a single dose for COVID-19 immunisation. Medical history included hay fever and allergy to pollen. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 14Jun2021 at 23:00, the patient experienced light pain in arm, headache and light-headedness. On 15Jun2021 the patient experienced rash about 1 inch in size that appeared about a day after vaccination. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event light pain in arm, headache, light-headedness and rash was recovered on an unknown date in Jun2021. No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652797
Sex: F
Age:
State: ME

Vax Date: 06/16/2021
Onset Date: 06/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Nose bleed; Painful arm; Headache; Body aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old, non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 16Jun2021 at 11:30 (at the age of 21-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included carbamazepine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), Montelukast sodium (SINGULAIR) and medroxyprogesterone acetate (DEPOPROVERA); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 27May2021 at 13:30 (at the age of 21-years-old), as a single dose for COVID-19 immunisation. The patient previously took fluoxetine hydrochloride (PROZAC) and clonidine (MANUFACTURER UNKNOWN); both on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Jun2021 at 07:30, the patient experienced nose bleed, painful arm, headache, body aches and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nose bleed, painful arm, headache, body aches and fatigue were resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: CARBAMAZEPINE; BUPROPION; SINGULAIR; DEPOPROVERA

Current Illness:

ID: 1652798
Sex: F
Age:
State: MI

Vax Date: 06/14/2021
Onset Date: 06/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Tender lymph nodes; Very large, swollen and groin right and left lymph nodes.; Slight headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0172) via an unspecified route of administration in the left arm on 14Jun2021 at 09:00(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0172) via an unspecified route of administration in the left arm on 21May2021 at 16:00(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 15Jun2021, the patient experienced slight headache. On 16Jun2021, the patient experienced very large, swollen and tender left arm lymph nodes. On 18Jun2021, the patient experienced swollen and tender right groin lymph nodes. No therapeutic measures were taken as a result of adverse events. The clinical outcome of the event slight headache, very large tender swollen and tender left arm lymph nodes, swollen and tender right groin lymph nodes was not recovered at the time of this report.

Other Meds:

Current Illness:

ID: 1652799
Sex: M
Age:
State: TX

Vax Date: 05/06/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: My Left Hand is having pain for 2 months where the vaccine is put and it get worst as days go from the date of vaccination; This is a spontaneous report from a contactable consumer. A 46-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176), dose 1 via an unspecified route of administration, administered in Arm Left on 06May2021 03:00 (at the age of 46-years-old) as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not have any allergies. The patient had no other vaccine within four weeks and no other medications received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced his left hand was having pain for 2 months where the vaccine was put and it get worst as days go from the date of vaccination on 11May2021. The patient did not receive any treatment. Outcome of the event was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652800
Sex: F
Age:
State: VA

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: mild case of shingles; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 at 12:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included ethinylestradiol, norgestimate (ESTARYLLA) taken from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 21:00, the patient experienced mild case of shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with antibiotics. The clinical outcome of the event shingles was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ESTARYLLA

Current Illness:

ID: 1652801
Sex: F
Age:
State: NJ

Vax Date: 06/16/2021
Onset Date: 06/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Discoloration on and under the spot on the left arm,; blister that keeps getting bigger with pus in it.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Jun2021 at 14:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had no known allergies. Concomitant medications included loratadine (CLARITIN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Jun2021 at 00:00, the patient experienced discoloration on and under the spot on the left arm, blister that kept getting bigger with pus in it. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events discoloration on and under the spot on the left arm, blister that kept getting bigger with pus in it was unknown. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds: CLARITIN [LORATADINE]

Current Illness:

ID: 1652802
Sex: M
Age:
State: TX

Vax Date:
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210612; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: 02Feb2021=1dose and 02Feb2021=2dose; Hand Joint pain; Hand Joint pain and swelling; This is a spontaneous report from a contactable consumer. This 53-year-old male consumer reported for a himself. A 53-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: EZ9266), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date as DOSE 2, SINGLE, dose 1 via an unspecified route of administration, administered in Arm Left on 02Feb2021 15:45 (Batch/Lot Number: EN5318) as DOSE 1, SINGLE for covid-19 immunization. Concomitant medication(s) included escitalopram oxalate (LEXAPRO), esomeprazole magnesium (NEXIUM MUPS [ESOMEPRAZOLE MAGNESIUM]) montelukast (MONTELUKAST) taken for an unspecified indication, start and stop date were not reported. On 12Jun2021 The patient underwent lab tests and procedures which included sars-cov-2 test: negative. No other vaccine in four weeks. No Covid test prior vaccination. On an unspecified date The patient experienced 02feb2021=1dose and 02feb2021=2dose, On 20May2021 05:15 hand joint pain, hand joint pain and swelling. Events were consider as non serious. Therapeutic measures were taken as a result of hand joint pain, hand joint pain and swelling. The outcome of events hand joint pain, hand joint pain and swelling were not resolved and rest was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds: LEXAPRO; NEXIUM MUPS [ESOMEPRAZOLE MAGNESIUM]; MONTELUKAST

Current Illness:

ID: 1652803
Sex: M
Age:
State: NJ

Vax Date: 06/17/2021
Onset Date: 06/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Headache; Fever; This is a spontaneous report from a contactable pharmacist. A male patient of an unspecified age received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 17Jun2021 at 16:00 as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient's past drug history was reported as no. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Jun2021, the patient experienced headache and fever. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen (ADVIL) and acetaminophen (TYLENOL). The clinical outcome of the events, headache and fever was recovering at the time of this report.

Other Meds:

Current Illness:

ID: 1652804
Sex: F
Age:
State: MN

Vax Date: 02/28/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Blood Pressure; Result Unstructured Data: Test Result:High

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Ringing in ears two days after first shot which continues to present day; Two incidents (1.5 and 2 weeks) after 1st shot that later was found caused by enlarged aorta - sweating, dizzines; sweating; dizziness; exhaustion; racing heart; This is a spontaneous report from a contactable consumer or other non hcp. A 60-year-old female patient received first dose bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number: EN6205; Expiration date was not reported) via an unspecified route of administration, administered in Arm Left on 28Feb2021 13:30 as DOSE 1, SINGLE, second dose bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number: ER2613; Expiration date was not reported) via an unspecified route of administration, administered in Arm Left on 21Mar2021 15:30 (age at vaccination 60-year-old) as DOSE 2, SINGLE for covid-19 immunization. Facility type vaccine Other. There were no other vaccine in four weeks. No other medications in two weeks. Medical history included known allergies: Penicillin (penicillin). The patient's concomitant medications were not reported. Ringing in ears two days after first shot which continues to present day 18Jun2021. Two incidents (1.5 and 2 weeks) after 1st shot that later was found caused by enlarged aorta - sweating, dizziness, racing heart, exhaustion. Never had heart trouble, do not smoke, do not have high blood pressure. On an unspecified date the patient experienced ringing in ears two days after first shot which continues to present day, two incidents (1.5 and 2 weeks) after 1st shot that later was found caused by enlarged aorta - sweating, dizziness, sweating, dizziness, exhaustion, racing heart. Ae resulted in [Doctor or other healthcare professional office/clinic visit]. The patient underwent lab tests and procedures which included blood pressure measurement: high. The outcome of events ringing in ears two days after first shot which continues to present day, two incidents (1.5 and 2 weeks) after 1st shot that later was found caused by enlarged aorta - sweating, dizziness, sweating, dizziness were not recovered and for events exhaustion, racing heart were unknown. Follow-up (19Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652805
Sex: F
Age:
State: TX

Vax Date: 05/28/2021
Onset Date: 05/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Throat tightness; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 40-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: GW0170), via an unspecified route of administration (at the age of 40-years), administered in arm left on 28May2021 13:00 as dose 1, single for COVID-19 immunization. Medical history included none from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccine in four weeks. The patient had no covid prior vaccination and has not been tested for covid post vaccination. The patient had no known allergies. On 28May2021, the patient stated that within 5 minutes of receiving the vaccine, I felt throat tightness which lasted 2-3 seconds. It occurred three times. It did not interrupt my breathing. The treatment was not received for the event. The facility type of vaccine reported as pharmacy or drug store. The clinical outcome for the events was reported as recovered on an unspecified date in 2021. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652806
Sex: F
Age:
State: WY

Vax Date: 06/09/2021
Onset Date: 06/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210609; Test Name: Body temperature; Result Unstructured Data: Test Result:102 Units:{DF}; Comments: at 15:00

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Fever 102 for three days; Nausea; Weak; Soreness in shot area; This is a spontaneous report from a contactable other healthcare professional, the patient. An 85-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 09Jun2021 at 00:00 (at the age of 85-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 09Jun2021 at 15:00, the patient experienced fever 102 (units unspecified) for three days, weak, nausea and soreness in shot area. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the event fever 102 for three days was recovered on 12Jun2021. The outcome of the events weak, nausea and soreness in shot area were recovered on unspecified date Jun2021.

Other Meds:

Current Illness:

ID: 1652807
Sex: F
Age:
State: CT

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Headache; Neck spasm; muscular pain; Shoting pain in the head; Jaw pain; Burning; tingling; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11May2021 at 10:00(at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and unspecified allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included naproxen (MANUFACTURER UNKNOWN) and naratriptan (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, the patient experienced headache, neck spasm, muscular pain, shooting pain in the head, jaw pain, burning and tingling. The events result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events which included treatment with different medication but none of them helped. The clinical outcome of the events headache, neck spasm, muscular pain, shooting pain in the head, jaw pain, burning and tingling were not resolved at the time of reporting. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds: NAPROXEN; NARATRIPTAN

Current Illness:

ID: 1652808
Sex: F
Age:
State: CA

Vax Date: 06/15/2021
Onset Date: 06/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Arm hot; large red circle; This is a spontaneous report from a non-contactable consumer. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Jun2021 at 16:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not know about any medications received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Jun2021 at 14:00, after three days of vaccination, the patient experienced arm hot and large red circle. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of arm hot and large red circle was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652809
Sex: F
Age:
State: GA

Vax Date: 02/25/2021
Onset Date: 04/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: hair has been shedding and falling out; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EL9266) via an unspecified route of administration, administered in left arm on 25Feb2021 10:00 as single dose for covid-19 immunisation. The patient's medical history included stroke, aneurysm, high blood pressure from an unknown date and unknown if ongoing. The patient previously took statins and experienced allergies. The patient's concomitant medications included telmisartan, amlodipine, omeprazole and aspirin at 81 mg. On 24Apr2021 10:30 AM, the patient experienced hair has been shedding and falling out. Patient reported that from end of Apr2021 through now, her hair has been shedding and falling out. Currently she was taking good hair high power synergistical food supplements, but it still sheds and falls out. Patient was wondering if Pfizer with her medicine has cause an issue and she trying to find out why her hair is shedding since it had never happened in the past. Therapeutic measures were taken as a result of my hair has been shedding and falling out. The outcome of the event was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: TELMISARTAN; AMLODIPINE; OMEPRAZOLE; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1652810
Sex: F
Age:
State: OH

Vax Date: 06/17/2021
Onset Date: 06/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: fluid filled blisters at vaccination site; have fluid filled blisters at injection site, they itch; have fluid filled blisters at injection site, they itch, red in area as well; This is a spontaneous report from a contactable nurse, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Jun2021 at 16:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. The patient was allergic to penicillin. Concomitant medications included ciprofloxacin (MANUFACTURER UNKNOWN), taken for an unspecified indication from an unknown date. The patient previously took emycin and clindamycin and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jun2021, the patient had fluid filled blisters at injection site, they itched and the area was red. Therapeutic measures were taken as a result of the events and included treatment with benadryl. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events fluid filled blisters at injection site, itchy and red were not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow-up.

Other Meds: Ciprofloxacin

Current Illness:

ID: 1652811
Sex: F
Age:
State: MO

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: sever pain in my left elbow; Pain is going all the way to my hands and is making me drop things; Sever pain in left sholder; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date (at the age of 32-year-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date the patient experienced severe pain in left elbow and left shoulder and the pain was going all the way to hands and was making the patient to drop things. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe pain in left elbow and left shoulder and pain was going all the way to hands and was making the patient to drop things was not recovered at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652812
Sex: F
Age:
State: MD

Vax Date: 06/19/2021
Onset Date: 06/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Swelling of the lips; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Jun2021 at 11:45 (at the age of 15-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (TYLENOL) from an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Jun2021 at 12:45, the patient experienced swelling of the lips. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling of the lips was unknown at the time of this report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds: TYLENOL

Current Illness:

ID: 1652813
Sex: F
Age:
State: CA

Vax Date: 06/19/2021
Onset Date: 06/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Rashes and hives all over my arms, legs, and stomach.; Rashes and hives all over my arms, legs, and stomach.; Skin very itchy; Forearms especially were swollen; The arm which got the vaccine on was very sore and painful to raise; The arm which I got the vaccine on is very sore and painful to raise.; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the right arm on 19Jun2021 at 12:00 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Jun2021 at 13:00 the patient experienced rashes and hives all over the arms, legs, and stomach. The patient skin was very itchy and forearms especially were swollen. The arm which the patient got the vaccine on was very sore and painful to raise. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events rashes all over arms, legs and stomach, hives all over arms, legs and stomach, skin very itchy, forearms especially was swollen, the arm which got the vaccine on was very sore and painful to raise was not recovered at the time of this report.

Other Meds:

Current Illness:

ID: 1652814
Sex: M
Age:
State: NY

Vax Date: 06/19/2021
Onset Date: 06/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Severely swollen eye lid; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Jun2021 at 17:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder. The patient took unspecified other medication in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Jun2021 at 21:00, the patient experienced severely swollen eye lid. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event swollen eye lid was not recovered. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652815
Sex: M
Age:
State: IN

Vax Date: 06/18/2021
Onset Date: 06/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Swollen lymph node left armpit; This is a spontaneous report from a contactable consumer (Patient). A 51-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: Blm0196) via an unspecified route of administration, administered in Arm Left on 18Jun2021 15:00 as single dose for covid-19 immunization at Pharmacy or Drug Store. The patient medical history and concomitant medications was not reported. Previously patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: Blm0176) via an unspecified route of administration, administered in Arm Left on 27May2021 15:00 as single dose for covid-19 immunization. Patient had not Known allergies. The patient experienced swollen lymph node left armpit on 19Jun2021. Patient did not COVID prior vaccination. Patient did not COVID tested post vaccination. No other vaccine in four weeks. Patient had no treatment. The outcome of the event was unknown. Follow-Up (20Jul2021): Follow-up attempts are completed. No further information is expected. Follow-Up (05Aug2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652816
Sex: F
Age:
State: VA

Vax Date: 06/01/2021
Onset Date: 06/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210611; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Suffering severe migraines that won't go away; Heart beat spikes; Sinus infection; General feeling of unwell; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 01Jun2021 at 11:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Jun2021, three weeks since first dose the patient was suffering with severe migraines "that won't go away", heart beat spikes, had sinus infection migraines and general feeling of unwell. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with antibiotics. On 11Jun2021, the patient underwent COVID-19 Nasal Swab test and the result was negative. The clinical outcome of the events severe migraines, heart beat spikes, sinus infection migraines and general feeling of unwell were not recovered at the time of this report. The lot number for BNT162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652817
Sex: F
Age:
State: OH

Vax Date:
Onset Date: 05/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Red spot on arm; Sore; Itchy; This is a spontaneous report from a contactable consumer (patient herself). A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number and Expiry date were not reported) via an unspecified route of administration in the right arm on an unspecified date in 15:45 and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number and Expiry date were not reported) via an unspecified route of administration in the right arm on 17Jun2021 14:45 (at the age of 49-years-old) as a single dose for COVID-19 immunization. Medical history included meniers disease, obesity. The patient concomitant medications were not reported. The patient was not pregnant at time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took morphine (MANUFACTURER UNKNOWN) on unknown date for an unspecified indication and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 17May2021 at 15:45, the patient had experienced red spot-on arm, sore and itchy and stayed that way for 2 weeks. The patient receive treatment for the adverse event Spot still on arm, but soreness and itchiness gone with the first dose used cortisone cream. Got the second dose on 17Jun2021 same thing happened but much more intense. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events which included cortisone cream but not helping on second dose. The outcome of the events was not recovered. Information on Lot/Batch number was not available. Additional information has been requested.

Other Meds:

Current Illness:

ID: 1652818
Sex: F
Age:
State: WA

Vax Date: 01/08/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202106; Test Name: Blood test; Result Unstructured Data: Test Result:diagnosed with anemia; Comments: patient was very anemic for the first time in life; Test Date: 202012; Test Name: Blood test; Result Unstructured Data: Test Result:normal results; Comments: patient had normal blood work

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Now i am very anemic for the first time in my life; This is a spontaneous report from a contactable healthcare professional, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Jan2021 at 18:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included liraglutide (SAXENDA) and dicycloverine (DICYCLOMINE) for unknown indications from unknown start date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01Apr2021 at 00:00 the patient had new blood work (blood test) in June 2021, then patient was very anemic for the first time in her life. patient thought it had something to do with the vaccine. On an unknown date in Dec2020, the patient underwent Blood test and the result was normal results. On an unknown date in Jun2021, the patient underwent Blood test and the result was diagnosed with anemia. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the reported event. The clinical outcome of the events very anemic for the first-time in-patient life was unknown at the time of this report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds: SAXENDA; DICYCLOMINE

Current Illness:

ID: 1652819
Sex: F
Age:
State: CT

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: The patient developed a low fever a day after the second dose of vaccination. The fever lasted for a day.; The patient continued to feel fatigue for six days.; This is a spontaneous report from a contactable consumer. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 19Feb2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 20Feb2021, the patient experienced a low fever a day after the second dose of vaccination. The fever lasted for a day. The patient continued to feel fatigue for six days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if the patient received any treatment for the events. The clinical outcome of the event a low fever after the second dose of vaccination recovered on 21Feb2021. While that of felt fatigue was recovered on 26Feb2021. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652820
Sex: F
Age:
State:

Vax Date: 06/18/2021
Onset Date: 06/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Arm pain; Very low, depressed thoughts that are very much out of the ordinary; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Jun2021 at 09:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included colon cancer and depressive state. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Jun2021 at 16:00 the patient experienced very low, depressed thoughts that are very much out of the ordinary and arm pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events very low, depressed thoughts that are very much out of the ordinary and arm pain was not recovered. Follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1652821
Sex: M
Age:
State: MA

Vax Date: 05/13/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210527; Test Name: Tympanometry; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210527; Test Name: Audiogram; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Unilateral tinnitus (right ear) on 16May21 at 21:00 turned into bilateral tinnitus on 17May2021 at 07:00 (~12kHz tone and slight ~4kHz tone both in both ears).; Sleep was interrupted; Slight dizziness; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the arm left on 13May2021 at 12:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY) for unspecified indication since unspecified date within two weeks. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took prednisone (MANUFACTURER UNKNOWN), asprin (MANUFACTURER UNKNOWN); both were taken for unspecified indication since an unspecified date and experienced drug allergy. The patient experienced unilateral tinnitus (right ear) on 16May21 at 21:00 turned into bilateral tinnitus on 17May2021 at 07:00; it was (~12kHz tone and slight ~4kHz tone both in both ears). On 16May2021 at 21:00, the patient's sleep was interrupted and had slight dizziness accompanied the unilateral tinnitus only. The events resulted in doctor or other healthcare professional office/clinic visit. It was reported that, the patient had primary care visit on 25May2021. Therapeutic measures were not taken as a result of events. On 27May2021, the patient underwent audiogram, tympanometry and the results were unknown. The events bilateral tinnitus and sleep interrupted was persisted. The event resulted in ENT visit on 10Jun2021 . The clinical outcome of the event unilateral tinnitus , sleep was interrupted; slight dizziness were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ONE-A-DAY [ASCORBIC ACID;CYANOCOBALAMIN;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL

Current Illness:

ID: 1652822
Sex: F
Age:
State: CA

Vax Date: 06/04/2021
Onset Date: 06/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Genital ulcers; This is a spontaneous report from a contactable physician. A 15-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 04Jun2021 (at the age of 15-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 06Jun2021, 2 days after the second COVID vaccine, the patient had genital ulcers. It was also reported that it was unclear if related to vaccine but didn't have another explanation. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of genital ulcers and included treatment with antifungal creams, fluconazole (MANUFACTURER UNKNOWN), triamcinolone (MANUFACTURER UNKNOWN) ointment. The clinical outcome of the event genital ulcers was recovering at the time of this report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652823
Sex: F
Age:
State: NY

Vax Date: 06/18/2021
Onset Date: 06/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: dry throat; my arm pits started sweating extremely; Left hand was feeling a little heaven; I started having pain in my forearm; my left thigh had pain and another nodule; my left thigh had pain and another nodule; This is a spontaneous report from a contactable consumer (patient herself). A 38-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 18Jun2021 01:30 (age at vaccination: 38 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included stroke, clots ,miscarriages and antiphospholipid syndrome. Concomitant medication(s) included levofloxacin (LOVENOX).The patient previously took hydromorphone hcl for hypersensitivity, macrobid [clarithromycin] for hypersensitivity, minocin akne for hypersensitivity, flagyl 250 for hypersensitivity. On 18Jun2021 13:45, the patient experienced dry throat, her arm pits started sweating extremely, left hand was feeling a little heaven, she started having pain in her forearm, her left thigh had pain and another nodule. After 2 mins of taking the first shot she had dry throat, with in 30 mins wait time she experience dry throat, her arm pits started sweating extremely. Left hand was feeling a little heaven that she started having pain in her forearm when she checked there was a dump that was hurting the nurses said it was nothing. But it was hurting she ended up in the emergency room. The doctors explained the nodules are getting inflamed in some people . By 7 pm her left thigh had pain and another nodule. She took Lovenox dose. She still have pain but the nurses and doctors are understanding the pain. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 nor was tested for covid-19 since vaccination. The outcome of all the events was not recovered. The device date was 19Jun2021.

Other Meds: LOVENOX [LEVOFLOXACIN]

Current Illness:

ID: 1652824
Sex: F
Age:
State: SC

Vax Date: 05/30/2021
Onset Date: 06/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Longer heavier menstruation; This is a spontaneous report from a contactable consumer (patient) reporting for herself. A 37-year-old non-pregnant female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), via an unspecified route of administration on 30May2021 15:00 (at the age of 37-years-old) (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. Medical history included Ivf (in vitro fertilization) failure one month prior from an unknown date and unknown if ongoing. The patient had previously known allergies: penicillin. There were no concomitant medications. The patient experienced longer heavier menstruation on 01Jun2021. Patient did not receive any treatment. Patient did not receive any other vaccines within 4 weeks prior and other medications 2 weeks prior to the COVID vaccine. The patient was not tested for covid 19 prior to vaccination and had not been tested post vaccination. The outcome of the event was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652825
Sex: F
Age:
State: WI

Vax Date: 06/18/2021
Onset Date: 06/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Later I became nauseous; Headache; Injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 18Jun2021 at 08:00 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported and the patient was allergic to amoxicillin (MANUFACTURER UNKNOWN) .Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Jun2021 at 08:00, right after the shot, the patient experienced injection site pain and on 18Jun2021 at 10:00, later in the day (about 3 hours later), the patient became nauseous with a headache. No therapeutic measures were taken for the reported events. The clinical outcome of the event injection site pain, nauseous and headache was not recovered at the time of this report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652826
Sex: M
Age:
State: NY

Vax Date: 03/24/2021
Onset Date: 03/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210526; Test Name: COVID-19 virus test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Vomiting

Symptoms: dizzy spell approx. 20 mins afterinjection/ general lightheaded feeling persisted.; heart palpitations; heavy anxiety culminating in a panic attack; heavy anxiety culminating in a panic attack; brain fog; fatigue; pins & needles in hands and legs; occasional tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 24Mar2021 at 09:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had no known allergies. Patient did not receive other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 09:30 the patient experienced dizzy spell approx. 20 minutes after injection, that passed quickly but a general lightheaded feeling persisted. On an unknown date in 2021, the patient experienced (in next few days started having) heart palpitations and heavy anxiety culminating in a panic attack. palpitations worsened at night, especially when lying down. light headedness, brain fog, heart palpitations, fatigue, pins and needles in hands and legs, occasional tinnitus all persist almost 4 months later. The events resulted in emergency room/department or urgent care. The patient did not receive any treatment for the events. On 26May2021, the patient underwent COVID-19 virus test (Nasal swab) and the result was Negative. The clinical outcome of the events dizzy spell, a general lightheaded feeling, heart palpitations and heavy anxiety culminating in a panic attack, brain fog, heart palpitations, fatigue, pins and needles in hands and legs, occasional tinnitus was not recovered.

Other Meds:

Current Illness:

ID: 1652827
Sex: F
Age:
State: NJ

Vax Date: 06/14/2021
Onset Date: 06/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Hearing problems in left ear; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Jun2021 at 09:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included dupuytrens disease and osteoarthritis. It was unknown if the patient had known allergies to medications, food or other products. Concomitant medications included magnesium (MANUFACTURER UNKNOWN), ubidecarenone (COQ10), boron (MANUFACTURER UNKNOWN), vitamin d (MANUFACTURER UNKNOWN), vitamin e (MANUFACTURER UNKNOWN) and vitamin b (MANUFACTURER UNKNOWN), all were taken for unknown indication, on an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Jun2021 at 19:00, the patient experienced hearing problems in left ear. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event. The clinical outcome of the event hearing problems in left ear was not resolved at the time of report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds: MAGNESIUM; COQ10 [UBIDECARENONE]; BORON; VITAMIN D [VITAMIN D NOS]; VITAMIN E [VITAMIN E NOS]; VITAMIN B [VITAMIN B NOS]

Current Illness:

ID: 1652828
Sex: F
Age:
State:

Vax Date: 05/06/2021
Onset Date: 05/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210517; Test Name: Heart rate; Result Unstructured Data: Test Result:90 beats per minute; Comments: 90 beats per minute

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Rapid heart rate day 2 ,3, and 4 of 90 beats per minute; Heart felt like it was beating very heavy; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06May2021 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient did not receive any medication within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17May2021, the patient experienced rapid heart rate on the days 2 ,3, and 4 which was 90 beats per minute and heart felt like it was beating very heavy. The patient reported that she will not be getting her second dose, she was a perfectly healthy 125 pounds gal and the second dose scared her. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event rapid heart rate and heart felt like it was beating very heavy were resolved on an unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652829
Sex: F
Age:
State: CA

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Tongue swelling about an hour after. Lasted a few hours; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 18May2021 at 12:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included essential oils allergy except lavender and penicillin allergy. The patient did not receive any concomitant medications. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021 at 13:30, the patient experienced tongue swelling about an hour after. Lasted a few hours. Therapeutic measures were not taken as a result of this event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tongue swelling about an hour after. Lasted a few hours was recovered on 18May2021. The batch/lot numbers for BNT162b2 were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652830
Sex: F
Age:
State: MO

Vax Date: 06/09/2021
Onset Date: 06/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Slight soreness after vaccination then injection site was normal; Injection site was normal till yesterday when it became very itchy; A hard knot the size of half dollar has developed and site slightly swollen.; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 09Jun2021 at 15:45 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Concomitant medications were not reported. The patient previously took propylthiouracil (MANUFACTURER UNKNOWN) on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Jun2021, the patient experienced slight soreness after vaccination then injection site was normal till yesterday when it became very itchy and a hard knot the size of half dollar has developed, site is slightly swollen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events slight soreness after vaccination then injection site was normal till yesterday when it became very itchy and a hard knot the size of half dollar has developed, site is slightly swollen were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652831
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Aching pain; Coughing/Very hard to cough; Wheezing; It is like very bothering that I cannot sleep; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that patient took the vaccine on Wednesday. The patient experienced aching pain, coughing/very hard to cough, wheezing, it is like very bothering that i cannot sleep (non-serious) on an unspecified date. The outcome of events was unknown. It was reported that consumer hung up phone abruptly. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am